Non-alcoholic steatohepatitis (NASH) Research Solutions Date Published: Aug 25, 2021 Video Signant’s SmartSignals solutions and team of experts can help you navigate common trial challenges in non-alcoholic steatohepatitis trials. You’ll be able to streamline and simplify your study, while ensuring endpoints are of the highest quality. Educate & engage patient Collect reliable endpoints Assess cognitive function Compare objective sleep & activity measures with patient-reported outcomes Share: LinkedInTweet